Vitro Diagnostics, Inc.: Vitro Signs Letter of Intent to Form Strategic Alliance With European Biotechnology Firm
22nd Sep 2005, 07:59 GMT
AURORA, CO (MARKET WIRE) Vitro Diagnostics, Inc. (OTC BB: VODG), a biotechnology company, executed a binding letter of intent to form a broad-ranging strategic alliance with BioCare Europe headquartered in Rome, Italy. The partnership includes various agreements with regard to commercialization of Vitro's stem cell lines for use in research and development and cross licenses to fertility drug technology and products owned by both Vitro and BioCare.
Latest news from Market Wire - Pharmaceuticals and Biotech:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- IBEX TECHNOLOGIES INC.: IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- Daiichi Sankyo, Inc.: First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Daiichi Sankyo, Inc.: WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Targeted Genetics Corporation: Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- Crucell N.V.: Crucell Announces Third Quarter 2006 Results
- Acambis PLC: Acambis PLC announces Update on US MVA procurement
- SkyePharma PLC: SkyePharma PLC announces Board Appointment
- Base Technologies, Inc.: Base Technologies Award of Air Force Surgeon General Contract Continues Rapid Growth Trend
- Eugene Science, Inc.: Eugene Science Signs Major Distribution Agreement With RexGene Biotech